If a child's home environment is poor, early education programs can't be beneficial. Indicate ...

Author Question: If a child's home environment is poor, early education programs can't be beneficial. Indicate ... (Read 40 times)

cookcarl

Hero Member
Posts: 539

on: Jun 22, 2018

If a child's home environment is poor, early education programs can't be beneficial.

Indicate whether this statement is true or false.

Question 2

Jorge is learning Spanish and English simultaneously in his home. Equally fluent in both, he is a balanced bilingual.

Indicate whether this statement is true or false.

annierak

Sr. Member
Posts: 340

Reply #1 on: Jun 22, 2018

Answer to Question 1

False

Answer to Question 2

True

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.